Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting

Elise Pelletier (), Paula Smith, Kristina Boye, Derek Misurski, Sandra Tunis and Michael Minshall

Applied Health Economics and Health Policy, 2008, vol. 6, issue 2, 103-112

Abstract: These costing results provide an important resource for economic modelling and other types of costing research related to treating diabetes-related complications within the US managed care system. Copyright Adis Data Information BV 2008

Date: 2008
References: View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
http://hdl.handle.net/10.1007/BF03256126 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:aphecp:v:6:y:2008:i:2:p:103-112

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40258

DOI: 10.1007/BF03256126

Access Statistics for this article

Applied Health Economics and Health Policy is currently edited by Timothy Wrightson

More articles in Applied Health Economics and Health Policy from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().